A Multi-centre Chart Review study of stage I-III Non-Small Cell Lung Cancer in China - MAP

Study identifier:D133FR00236

ClinicalTrials.gov identifier:NCT07316062

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

A Multi-centre Chart Review study on the treatment patterns and outcomes of stage I-III Non-Small Cell Lung Cancer in China

Medical condition

non-small-cell lung

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

3000

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 29 Apr 2026
Estimated Primary Completion Date: 30 Apr 2029
Estimated Study Completion Date: 30 Apr 2029

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2026 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria